Back

Orient EuroPharma expands Rapifort license to 10 member states

Verifying
  • Orient EuroPharma expanded its strategic partnership with Maruho for Rapifort.
  • Rapifort’s licensing scope now covers Taiwan and all 10 member states.
  • Maruho is a century-old Japanese specialty pharmaceutical company focused on dermatology.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Orient EuroPharma expands Rapifort license to 10 member states - CoinPost Terminal